• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Women’s Health Investment Round-up (March 2025)

By Femtech Insider Investment, News April 2, 2025
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Famtech, Investment, News May 8, 2023
Mi Alma Raises $1.5M in Pre-seed Funding for Its Platform Supporting Families Dealing with Grief
Biotech, News, Pregnancy October 29, 2024
Rallybio to Begin First Clinical Trial for Prevention of Rare Pregnancy Blood Disorder
Recent Posts
  • BlueWind Medical Raises $47.8M to Commercialize Implantable Neuromodulation Device for Urgency Urinary Incontinence
  • Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor
  • UroMems Raises $60M for Smart Implant to Treat Stress Urinary Incontinence
  • Autoimmunity BioSolutions Closes $1M Seed Extension for Genetically Targeted Autoimmune Therapy
  • The Cost Problem: Who Actually Gets to Benefit From Women’s Health Innovation?

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.